MedPath

山东新大陆制药有限公司

Ownership
-
Established
1999-02-02
Employees
-
Market Cap
-
Website
http://www.daluyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

137

NMPA:137

Drug Approvals

断血流分散片

Approval Number
国药准字Z20080099
Approval Date
May 11, 2024
NMPA

五味子糖浆

Approval Number
国药准字Z37021150
Approval Date
Apr 25, 2023
NMPA

藿香正气丸

Approval Number
国药准字Z20027320
Approval Date
Apr 25, 2023
NMPA

半夏糖浆

Approval Number
国药准字Z37021142
Approval Date
Mar 24, 2023
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H37023033
Approval Date
Mar 31, 2021
NMPA

Inosital Tablets

Product Name
肌醇片
Approval Number
国药准字H37023028
Approval Date
Mar 31, 2021
NMPA

Chloramphenicol Tablets

Product Name
氯霉素片
Approval Number
国药准字H37022679
Approval Date
Mar 31, 2021
NMPA

Ranitidine Hydrochloride Tablets

Product Name
盐酸雷尼替丁片
Approval Number
国药准字H37023034
Approval Date
Mar 31, 2021
NMPA

Chlorpromazine Hydrochloride Tablets

Product Name
盐酸氯丙嗪片
Approval Number
国药准字H37023036
Approval Date
Mar 31, 2021
NMPA

Nifedipine Tablets

Product Name
硝苯地平片
Approval Number
国药准字H37023032
Approval Date
Mar 31, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 14
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.